Bruker
Bruker develops scientific instruments and analytical and diagnostic solutions and makes strategic equity investments in life-sciences technology companies.
Bruker is a developer and manufacturer of high-performance scientific instruments and analytical and diagnostic solutions, and it makes strategic equity investments in life-sciences technology companies. For investors and operators evaluating corporate venture activity in the sector, the relevant distinction is that Bruker's investing is strategic rather than financial: capital is deployed alongside an operating business that supplies the instrumentation - nuclear magnetic resonance (NMR) spectrometers, microscopy systems, mass spectrometry, X-ray analysis, and infrared and Raman spectroscopy - into the same research and diagnostics markets in which it invests.
The instrument portfolio spans molecular and materials research, proteomics, cell biology, and industrial and applied analysis, serving both academic and industrial customers. Products are supported by software, consumables, and lifecycle services intended to sustain instrument uptime and productivity over the operating life of the installed base. Investment stage, check size, and portfolio composition are not disclosed in the information available here.
Bruker states its mission as helping researchers extend analytical capabilities and make discoveries that improve quality of human life. The combination of a broad analytical instrumentation franchise and equity participation in adjacent life-sciences technologies places the company among the strategic corporate investors active in research tools and diagnostics.